Switch theme
Sign up to access all valuation multiples
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular, and central nervous system products. It manufactures medicines including original, generic and licensed products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharma segment comprising Women’s Healthcare, Neuropsychiatry, Biotechnology, General Medicine, and Other pharma; and the Others segment includes the remaining wholesale and retail business of the Group and all other activities. The company operates internationally.
1923
11.6K+
LTM Revenue $2.4B
LTM EBITDA $877M
$5.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Gedeon Richter has a last 12-month revenue of $2.4B and a last 12-month EBITDA of $877M.
In the most recent fiscal year, Gedeon Richter achieved revenue of $2.2B and an EBITDA of $638M.
Gedeon Richter expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Gedeon Richter valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $2.2B | $2.2B | XXX | XXX | XXX |
| Gross Profit | $938M | $1.2B | XXX | XXX | XXX |
| Gross Margin | 44% | 57% | XXX | XXX | XXX |
| EBITDA | $597M | $638M | XXX | XXX | XXX |
| EBITDA Margin | 28% | 30% | XXX | XXX | XXX |
| Net Profit | $375M | $418M | XXX | XXX | XXX |
| Net Margin | 17% | 19% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Gedeon Richter's stock price is HUF 10280 (or $28).
Gedeon Richter has current market cap of HUF 1.88T (or $5.0B), and EV of HUF 1.87T (or $5.0B).
See Gedeon Richter trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5.0B | $5.0B | XXX | XXX | XXX | XXX | $3.64 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Gedeon Richter has market cap of $5.0B and EV of $5.0B.
Gedeon Richter's trades at 2.1x LTM EV/Revenue multiple, and 5.7x LTM EBITDA.
Analysts estimate Gedeon Richter's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Gedeon Richter and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $5.0B | XXX | XXX | XXX |
| EV/Revenue | 2.3x | XXX | XXX | XXX |
| EV/EBITDA | 7.9x | XXX | XXX | XXX |
| P/E | 11.8x | XXX | XXX | XXX |
| P/E/Growth | 0.3x | XXX | XXX | XXX |
| EV/FCF | 64.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpGedeon Richter's NTM/LTM revenue growth is 10%
Gedeon Richter's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Gedeon Richter's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Gedeon Richter's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Gedeon Richter and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 0% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 30% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 40% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 18% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 6% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 10% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 41% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Gedeon Richter acquired XXX companies to date.
Last acquisition by Gedeon Richter was XXXXXXXX, XXXXX XXXXX XXXXXX . Gedeon Richter acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Gedeon Richter founded? | Gedeon Richter was founded in 1923. |
| Where is Gedeon Richter headquartered? | Gedeon Richter is headquartered in Hungary. |
| How many employees does Gedeon Richter have? | As of today, Gedeon Richter has 11.6K+ employees. |
| Is Gedeon Richter publicy listed? | Yes, Gedeon Richter is a public company listed on BUD. |
| What is the stock symbol of Gedeon Richter? | Gedeon Richter trades under RICHTER ticker. |
| When did Gedeon Richter go public? | Gedeon Richter went public in 1994. |
| Who are competitors of Gedeon Richter? | Similar companies to Gedeon Richter include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Gedeon Richter? | Gedeon Richter's current market cap is $5.0B |
| What is the current revenue of Gedeon Richter? | Gedeon Richter's last 12-month revenue is $2.4B. |
| What is the current EBITDA of Gedeon Richter? | Gedeon Richter's last 12-month EBITDA is $877M. |
| What is the current EV/Revenue multiple of Gedeon Richter? | Current revenue multiple of Gedeon Richter is 2.1x. |
| What is the current EV/EBITDA multiple of Gedeon Richter? | Current EBITDA multiple of Gedeon Richter is 5.7x. |
| What is the current revenue growth of Gedeon Richter? | Gedeon Richter revenue growth between 2023 and 2024 was 0%. |
| Is Gedeon Richter profitable? | Yes, Gedeon Richter is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
